{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:53:44Z","timestamp":1781646824176,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Soochow University Collaborative Innovation Center Research Project","award":["H240669"],"award-info":[{"award-number":["H240669"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Central nervous system involvement in chronic graft-versus-host disease (CNS-cGVHD) is rare. This case report describes a young man who developed anti-glutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy after undergoing matched sibling donor hematopoietic stem cell transplantation. The therapeutic approach included intensive immunotherapy with methylprednisolone, immunoadsorption, Rituximab, and low-dose Daratumumab, in combination with four antiepileptic drugs and mycophenolate mofetil. This regimen led to a marked reduction in anti-GAD65 titers and an improvement in the NHS3 seizure severity score, decreasing from 8 to 3. Additionally, a review of the literature on post-transplant autoimmune encephalitis is also provided.<\/jats:p>","DOI":"10.1007\/s00277-026-06961-x","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:57:59Z","timestamp":1774846679000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: anti-GAD65 antibody-associated epilepsy as the primary manifestation of chronic graft-versus-host disease"],"prefix":"10.1007","volume":"105","author":[{"given":"Suge","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengchen","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingluan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"issue":"13","key":"6961_CR1","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1182\/blood.2023022735","volume":"144","author":"JA Pidala","year":"2024","unstructured":"Pidala JA, Gooley TA, Luznik L, Blazar BR (2024) Chronic graft-versus-host disease: unresolved complication or ancient history? [J]. Blood 144(13):1363\u20131373. https:\/\/doi.org\/10.1182\/blood.2023022735","journal-title":"Blood"},{"issue":"2","key":"6961_CR2","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/s2352-3026(23)00342-3","volume":"11","author":"O Penack","year":"2024","unstructured":"Penack O, Marchetti M, Aljurf M et al (2024) Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation [J]. Lancet Haematol 11(2):e147\u2013e59. https:\/\/doi.org\/10.1016\/s2352-3026(23)00342-3","journal-title":"Lancet Haematol"},{"issue":"1","key":"6961_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2022.12.024","volume":"90","author":"E Baumrin","year":"2024","unstructured":"Baumrin E, Loren AW, Falk SJ et al (2024) Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations [J]. J Am Acad Dermatol 90(1):1\u201316. https:\/\/doi.org\/10.1016\/j.jaad.2022.12.024","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"6961_CR4","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1093\/brain\/awq245","volume":"133","author":"O Grauer","year":"2010","unstructured":"Grauer O, Wolff D, Bertz H et al (2010) Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease [J]. Brain, 133(10): 2852-65. https:\/\/doi.org\/10.1093\/brain\/awq245","journal-title":"Brain"},{"issue":"30","key":"6961_CR5","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1200\/jco.2009.21.7919","volume":"27","author":"AG Saad","year":"2009","unstructured":"Saad AG, Alyea EP 3rd, Wen PY et al (2009) Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation [J]. J Clin Oncol 27(30):e147\u2013e149. https:\/\/doi.org\/10.1200\/jco.2009.21.7919","journal-title":"J Clin Oncol"},{"key":"6961_CR6","doi-asserted-by":"publisher","first-page":"675756","DOI":"10.3389\/fneur.2021.675756","volume":"12","author":"Z Wang","year":"2021","unstructured":"Wang Z, Zhao M, Gao S (2021) Epileptic seizures after allogeneic hematopoietic stem cell transplantation [J]. Front Neurol 12:675756. https:\/\/doi.org\/10.3389\/fneur.2021.675756","journal-title":"Front Neurol"},{"issue":"2","key":"6961_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/bmt.2017.239","volume":"53","author":"MR Dowling","year":"2018","unstructured":"Dowling MR, Li S, Dey BR et al (2018) Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact [J]. Bone Marrow Transpl 53(2):199\u2013206. https:\/\/doi.org\/10.1038\/bmt.2017.239","journal-title":"Bone Marrow Transpl"},{"issue":"6","key":"6961_CR8","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/mus.21153","volume":"38","author":"EC Clow","year":"2008","unstructured":"Clow EC, Couban S, Grant IA (2008) Stiff-person syndrome associated with multiple myeloma following autologous bone marrow transplantation [J]. Muscle Nerve 38(6):1649\u20131652. https:\/\/doi.org\/10.1002\/mus.21153","journal-title":"Muscle Nerve"},{"issue":"3","key":"6961_CR9","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.pediatrneurol.2015.05.011","volume":"53","author":"GS Rathore","year":"2015","unstructured":"Rathore GS, Leung KS, Muscal E (2015) Autoimmune Encephalitis Following Bone Marrow Transplantation [J]. Pediatr Neurol 53(3):253\u2013256. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2015.05.011","journal-title":"Pediatr Neurol"},{"issue":"4","key":"6961_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/practneurol-2018-001923","volume":"18","author":"A Randall","year":"2018","unstructured":"Randall A, Huda S, Jacob A, Larner AJ (2018) Autoimmune encephalitis (NMDAR antibody) in a patient receiving chronic post-transplant immunosuppression [J]. Pract Neurol 18(4):320\u2013322. https:\/\/doi.org\/10.1136\/practneurol-2018-001923","journal-title":"Pract Neurol"},{"issue":"1","key":"6961_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000494423","volume":"141","author":"L Shargian-Alon","year":"2019","unstructured":"Shargian-Alon L, Raanani P, Rozovski U et al (2019) Immune mediated cerebellar ataxia: an unknown manifestation of graft-versus-host disease [J]. Acta Haematol 141(1):19\u201322. https:\/\/doi.org\/10.1159\/000494423","journal-title":"Acta Haematol"},{"issue":"3","key":"6961_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.braindev.2018.10.006","volume":"41","author":"K Nagai","year":"2019","unstructured":"Nagai K, Maekawa T, Terashima H et al (2019) Severe anti-GAD antibody-associated encephalitis after stem cell transplantation [J]. Brain Dev 41(3):301\u2013304. https:\/\/doi.org\/10.1016\/j.braindev.2018.10.006","journal-title":"Brain Dev"},{"key":"6961_CR13","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3389\/fneur.2019.00987","volume":"10","author":"FF Konen","year":"2019","unstructured":"Konen FF, Schwenkenbecher P, Jendretzky KF et al (2019) Severe Anti-N-Methyl-D-Aspartate receptor encephalitis under immunosuppression after liver transplantation [J]. Front Neurol 10:987. https:\/\/doi.org\/10.3389\/fneur.2019.00987","journal-title":"Front Neurol"},{"issue":"1","key":"6961_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/10428194.2019.1658104","volume":"61","author":"R Thummalapalli","year":"2020","unstructured":"Thummalapalli R, Sena LA, Probasco JC, Gladstone DE (2020) Checkpoint inhibitor-induced autoimmune encephalitis reversed by rituximab after allogeneic bone marrow transplant in a patient with Hodgkin lymphoma [J]. Leuk Lymphoma 61(1):228\u2013230. https:\/\/doi.org\/10.1080\/10428194.2019.1658104","journal-title":"Leuk Lymphoma"},{"key":"6961_CR15","doi-asserted-by":"publisher","unstructured":"Spindel J, Heckroth M, Marsano L (2020) Antibody-negative autoimmune encephalitis as a complication of long-term immune-suppression for liver transplantation [J]. BMJ Case Rep 13(9). https:\/\/doi.org\/10.1136\/bcr-2020-235777","DOI":"10.1136\/bcr-2020-235777"},{"issue":"2","key":"6961_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s12185-020-02859-0","volume":"112","author":"J Toda","year":"2020","unstructured":"Toda J, Maeda T, Akuta K et al (2020) Limbic encephalitis with antibodies to N-methyl-D-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation [J]. Int J Hematol 112(2):254\u2013257. https:\/\/doi.org\/10.1007\/s12185-020-02859-0","journal-title":"Int J Hematol"},{"key":"6961_CR17","doi-asserted-by":"publisher","first-page":"1274420","DOI":"10.3389\/fimmu.2023.1274420","volume":"14","author":"MM Zhang","year":"2023","unstructured":"Zhang MM, Wang J, Sun D et al (2023) Case Report: Autoimmune encephalitis and other neurological syndromes with rare neuronal surface antibody in children after hematopoietic stem cell transplantation [J]. Front Immunol 14:1274420. https:\/\/doi.org\/10.3389\/fimmu.2023.1274420","journal-title":"Front Immunol"},{"issue":"3","key":"6961_CR18","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s10072-022-06560-4","volume":"44","author":"DZ Wang","year":"2023","unstructured":"Wang DZ, Li BH, Deng BL et al (2023) Anti-CASPR2 encephalitis in a liver posttransplant patient receiving immune-suppression and lenvatinib: a case report and literature review [J]. Neurol Sci 44(3):1069\u20131072. https:\/\/doi.org\/10.1007\/s10072-022-06560-4","journal-title":"Neurol Sci"},{"key":"6961_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/jbm.S472194","volume":"15","author":"J Liu","year":"2024","unstructured":"Liu J, Yang P, Hu M (2024) Encephalitis with antibodies against Glial Fibrillary Acidic Protein (GFAP) after allogeneic hematopoietic stem cell transplantation: a rare case report and literature review [J]. J Blood Med 15:359\u2013362. https:\/\/doi.org\/10.2147\/jbm.S472194","journal-title":"J Blood Med"},{"key":"6961_CR20","doi-asserted-by":"publisher","first-page":"1356691","DOI":"10.3389\/fneur.2024.1356691","volume":"15","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zhang X, Dai M et al (2024) Case report: A case of anti-glycine receptor encephalomyelitis triggered by post-transplant or COVID-19 infection? [J]. Front Neurol 15:1356691. https:\/\/doi.org\/10.3389\/fneur.2024.1356691","journal-title":"Front Neurol"},{"issue":"11","key":"6961_CR21","doi-asserted-by":"publisher","first-page":"101112","DOI":"10.1016\/j.xkme.2025.101112","volume":"7","author":"LA Dale","year":"2025","unstructured":"Dale LA, Prete A, Puyleart A et al (2025) A rare case of anti-glutamic acid decarboxylase 65 autoimmune encephalitis followed by acute graft-versus-host disease in simultaneous kidney and pancreas transplant [J]. Kidney Med 7(11):101112. https:\/\/doi.org\/10.1016\/j.xkme.2025.101112","journal-title":"Kidney Med"},{"issue":"2","key":"6961_CR22","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40265-022-01826-9","volume":"83","author":"J Flammer","year":"2023","unstructured":"Flammer J, Neziraj T, R\u00fcegg S, Pr\u00f6bstel AK (2023) Immune Mechanisms in Epileptogenesis: Update on Diagnosis and Treatment of Autoimmune Epilepsy Syndromes [J]. Drugs 83(2):135\u2013158. https:\/\/doi.org\/10.1007\/s40265-022-01826-9","journal-title":"Drugs"},{"issue":"7","key":"6961_CR23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1111\/epi.16571","volume":"61","author":"C Steriade","year":"2020","unstructured":"Steriade C, Britton J, Dale RC et al (2020) Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: Conceptual definitions [J]. Epilepsia 61(7):1341\u20131351. https:\/\/doi.org\/10.1111\/epi.16571","journal-title":"Epilepsia"},{"issue":"1","key":"6961_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-immunol-083122-044829","volume":"42","author":"I Abeles","year":"2024","unstructured":"Abeles I, Palma C, Meednu N et al (2024) B cell-directed therapy in autoimmunity [J]. Annu Rev Immunol 42(1):103\u2013126. https:\/\/doi.org\/10.1146\/annurev-immunol-083122-044829","journal-title":"Annu Rev Immunol"},{"key":"6961_CR25","doi-asserted-by":"publisher","first-page":"102724","DOI":"10.1016\/j.bcmd.2023.102724","volume":"99","author":"I Vernava","year":"2023","unstructured":"Vernava I, Schmitt CA (2023) Daratumumab as a novel treatment option in refractory ITP [J]. Blood Cells Mol Dis 99:102724. https:\/\/doi.org\/10.1016\/j.bcmd.2023.102724","journal-title":"Blood Cells Mol Dis"},{"issue":"6","key":"6961_CR26","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1111\/ene.15266","volume":"29","author":"F Scheibe","year":"2022","unstructured":"Scheibe F, Ostendorf L, Pr\u00fcss H et al (2022) Daratumumab for treatment-refractory antibody-mediated diseases in neurology [J]. Eur J Neurol 29(6):1847\u20131854. https:\/\/doi.org\/10.1111\/ene.15266","journal-title":"Eur J Neurol"},{"issue":"9","key":"6961_CR27","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s40263-022-00943-z","volume":"36","author":"A Dinoto","year":"2022","unstructured":"Dinoto A, Ferrari S, Mariotto S (2022) Treatment options in refractory autoimmune encephalitis [J]. CNS Drugs, 36(9): 919\u2009\u2013\u200931. https:\/\/doi.org\/10.1007\/s40263-022-00943-z","journal-title":"CNS Drugs"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06961-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06961-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06961-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:07:08Z","timestamp":1781644028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06961-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["6961"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06961-x","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"assertion":[{"value":"26 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The study was approved by the Ethics committee of the First Affiliated Hospital of Soochow University, China. The patient was fully informed and provided written informed consent for the publication of the case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"214"}}